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Abstract
Foetal alcohol spectrum disorders (FASDs) are a leading cause of developmental disability. Prenatal alcohol use is the sole 
necessary cause of FASD, but it is not always sufficient. Multiple factors influence a child’s susceptibility to FASD follow-
ing prenatal alcohol exposure. Much of the FASD risk factor literature has been limited to discussions of association, rather 
than causation. While knowledge of predictor variables is important for identifying who is most at risk of FASD and for 
targeting interventions, causal knowledge is important for identifying effective mechanisms for prevention and intervention 
programmes. We conducted a systematic search and narrative synthesis of the evidence and used this to create a causal 
diagram (directed acyclic graph; DAG) to describe the causal pathways to FASD. Our results show that the aetiology of 
FASD is multifaceted and complex. FASD risk is determined by a range of lifestyle, sociodemographic, maternal, social, 
gestational, and genetic factors. The causal diagram that we present in this review provides a comprehensive summary of 
causal risk factors for FASD and can be used as a tool to inform data collection and statistical modelling strategies to mini-
mise bias in future studies of FASD.
Keywords Foetal alcohol spectrum disorders · Causal diagram · Directed acyclic graph · Causal inference · Review · 
Prenatal exposures
Introduction
Foetal alcohol spectrum disorder (FASD) is an umbrella 
term that is used to describe a range of lifelong disabilities 
caused by prenatal alcohol exposure [1]. Individuals with 
FASD have neurodevelopmental impairments and some will 
also have growth deficiency and a distinctive facial pheno-
type, characterised by a thin upper lip, smooth philtrum 
and short palpebral fissure length [2]. Conservative esti-
mates suggest that around 2–5% of children in the general 
population of Europe and North America have FASD, mak-
ing it one of the leading causes of preventable developmental 
disability worldwide [3, 4]. Maternal alcohol use is the sole 
necessary cause of FASD, but it is not always sufficient [5]. 
Among women who drink any amount of alcohol in preg-
nancy, an estimated one in 13 will have a child with FASD 
and one in 67 will have a child with foetal alcohol syn-
drome (FAS) [4, 6]. Alcohol interacts with multiple factors 
in a complex process to determine offspring outcome [7]. 
Accordingly, rather than a simple causal chain, the image 
of a spider’s web has been considered most appropriate for 
describing the causal context of FASD [8].
Causal inference, the science of inferring the presence 
and magnitude of cause–effect relationships from data, is 
a central aim of epidemiology [9, 10]. However, much of 
the existing FASD literature simply lists risk factors and 
reports associations with little consideration of the under-
lying causal structure. The term ‘risk factor’ obscures the 
distinction between a predictor variable and a cause [11]. 
While knowledge of predictor variables is important for 
identifying who is most at risk of FASD and for targeting 
interventions, causal knowledge is important for identifying 
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effective mechanisms for prevention and intervention pro-
grammes [12].
Randomised controlled trials can be used to estimate 
causal effects. However, for many public health issues, 
including prenatal alcohol exposure (PAE), randomisation 
of exposure is unethical and/or unfeasible and, therefore, it 
is necessary to rely on observational data. Measures of (con-
ditional) association from observational designs can be used 
to estimate causal effects if conditional exchangeability is 
created by appropriate control of bias, such as adjustment for 
confounders [11]. Causal diagrams, known as directed acy-
clic graphs (DAGs), are gaining popularity as a gold stand-
ard method for supporting causal inference and reducing 
bias in epidemiological studies [13]. Judea Pearl devised the 
unifying framework that provided this graphical method and 
formal language for causal inference [14]. Pearl reasoned 
that the combination of observed data plus causal knowledge 
allows individuals to move beyond the realm of statistical 
association to that of causality. DAGs provide a tool for 
explicitly characterising assumptions about the causal rela-
tionships between exposures, covariates, and outcomes [15]. 
The graphical rules that underpin the interpretation of causal 
DAGs have a well-established mathematical basis [14]. They 
provide a systematic method for identifying which variables 
should be controlled for in the analysis, and which should 
not, to minimise bias in effect estimates, on the basis of the 
assumptions encoded in the DAG [14]. In scenarios where 
DAGs contain a large number of variables they become less 
clear as visual overviews of the causal context, but maintain 
their utility as a theory driven approach to statistical model-
ling strategies. In contrast to data-driven approaches, it is 
the hypothesised causal relationships depicted by the DAG, 
rather than measures of statistical significance that can be 
used to guide variable selection in subsequent quantitative 
analyses [16]. A detailed description of DAG language and 
theory is provided in Online Resource 1. In this review, we 
conduct a narrative literature synthesis and present a DAG 
to describe the hypothesised causal structure of the variables 
that are involved in the pathways to FASD. We also provide 
a worked example of how the DAG can be used to support 
statistical modelling strategies.
Method
Literature search
We searched Medline from inception to 2nd March 2016 
for existing systematic reviews of FASD risk factors using 
combinations of medical search headings (MeSH) and free 
text search terms for FASD, risk factors and reviews, as 
described in Online Resource 2. This search produced two 
references, one of which, by Esper et al. [17], was relevant 
to the aims of this review. To obtain more information about 
possible causal structures, we searched the full text articles 
of the included studies from this review and conducted sepa-
rate searches for each risk factor in Medline. In each search, 
we combined search terms for FASD and the relevant risk 
factor (see Online Resource 2 for example search on FASD 
and stress). Supplementary sources were searched to identify 
any risk factors that were not identified in the initial review 
and to provide further information on identified risk fac-
tors. Sources included: the Infant Feeding Survey [18–20], 
publications from the Millennium Cohort Study [21] and 
ALSPAC [22], the National Organization on Fetal Alcohol 
Syndrome and EUFASD newsletters, a search of study ref-
erence lists, Research Gate and FASD conference abstracts 
[23–25]. Supplementary searches were concluded on the 
22nd December 2017.
Evidence synthesis
To determine the most plausible structure for the aetiology 
of FASD, we used informal triangulation methods to evalu-
ate the evidence from the literature search. Unlike systematic 
reviews, which seek to compare results from studies that are 
relatively homogenous, triangulation seeks to compare evi-
dence from studies from a diverse range of approaches. The 
advantage of triangulation is that any biases are assumed 
to differ across the diverse study types. This increases con-
fidence in causal inferences if similar effect estimates are 
obtained [26].
DAG construction
We used the DAGitty platform [27] to draw and interpret 
a DAG based on the evidence synthesis. DAGitty code is 
provided in Online Resource 3.
Results
The DAG (Fig.  1) provides a visual description of the 
hypothesised aetiological context of FASD, based on the 
evidence synthesis.
In this section, we present the narrative synthesis of evi-
dence that supports the inclusion of factors in the DAG, and 
their position, followed by a worked example of how the 
DAG can be used to inform statistical modelling strategies. 
In Online Resource 4, we provide a more detailed descrip-
tion of the groupings of variables that were derived follow-
ing the evidence synthesis, to enable further comparison of 
the literature review with the causal (and non-causal) rela-
tionships depicted in the DAG.
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Patterns of maternal alcohol use (prenatal alcohol 
exposure)
During pregnancy, alcohol consumed by the mother passes 
freely through the placenta and within 1 h the level of alco-
hol within the foetal bloodstream approximates that of the 
mother [28]. For simplicity, we use term prenatal alcohol 
exposure (PAE) to refer to maternal alcohol use, although 
it is important to note that maternal alcohol use is just one 
element of foetal alcohol exposure, which is also influenced 
by maternal and infant metabolism and other modifying fac-
tors, described in this review.
The impact of PAE varies according to the dose, fre-
quency and timing of exposure. However, residual confound-
ing, measurement error and individual variability across a 
vast range of covariates complicate efforts to determine what 
pattern of maternal alcohol use will lead to FASD in an 
individual case. Nevertheless, on average, binge and heavy 
chronic patterns of maternal alcohol use are most likely to 
result in FASD [29–34]. Evidence on the effects of low to 
moderate PAE on developmental outcomes is limited and 
inconsistent, ranging from evidence of harm, to no effect, 
to evidence of slight benefit [35–44]. For example, Kelly 
et al. found that 3-year-old boys who were born to moth-
ers who reported drinking no more than one to two units 
of alcohol per week or per occasion during pregnancy had 
a lower risk of hyperactivity and conduct problems than 
those born to abstainers [40]. Negative control studies that 
compare the strength of association for maternal and pater-
nal exposures have also been used to investigate the causal 
effects of low to moderate PAE, but did not find evidence 
of intrauterine effects on child IQ or head circumference 
[41, 42]. In contrast, Mendelian randomisation studies have 
offered evidence that low to moderate PAE can cause per-
sistent conduct problems and adversely affect cognitive and 
academic outcomes [37, 38, 43]. Despite inconsistencies 
in the evidence, Mendelian randomisation studies provide 
stronger causal evidence than traditional observational stud-
ies that low to moderate alcohol use can cause adverse devel-
opmental outcomes. They suggest that the apparent null or 
protective effects of low to moderate PAE are likely to be 
due to residual confounding, owing to the socioeconomic 
patterning of prenatal alcohol use [36, 37, 44].
Alcohol use before pregnancy
Mothers of children with FASD are more likely to drink at 
high levels before pregnancy, to have had longer ‘drinking 
careers’ (i.e. more years of drinking alcohol), and to have 
a history of alcohol abuse, relative to controls [30, 32, 33, 
45]. Chronic alcohol use impairs the functioning of alcohol 
metabolising enzymes and can lead to malnutrition due to 
reduced intake and absorption of key nutrients, thus increas-
ing FASD risk [5, 46–49].
In the UK, up to 91% of women aged 16–45 report drink-
ing alcohol and excessive consumption is common [50, 51]. 
Few women follow guidance for prenatal alcohol use when 
planning a pregnancy [52] and alcohol use increases the 
risk of unplanned pregnancy [53–56]. Therefore, alcohol 
use prior to pregnancy is a significant risk factor for FASD.
Postnatal alcohol use
Mothers of children with FASD drink more heavily than 
controls postnatally [33, 57–65]. Of course, heavy postnatal 
alcohol use cannot cause FASD among children who have 
already been born. It can, however, indicate a continuing 
pattern of heavy alcohol use and serve as a risk marker for 
previous and future alcohol-exposed pregnancies. Heavy 
postnatal alcohol consumption may be a useful proxy 
for PAE. Studies from the USA and Italy found that self-
reported prenatal alcohol use was not consistently different 
between mothers of children with FASD and controls, but 
current consumption was higher [34, 63, 64]. In contrast, 
studies in the Western Cape of South Africa (where maternal 
self-report is believed to be more reliable, due to norma-
tive binge drinking patterns and higher levels of PAE) show 
consistently higher levels of self-reported PAE and current 
consumption among mothers of children with FASD [33, 
57–60, 62]. Therefore, postnatal drinking patterns may be 
particularly useful as a risk marker for previous PAE and 
for future FASD risk in populations that are susceptible to 
underreporting of PAE.
Smoking during pregnancy
Prenatal cigarette smoking is more common among mothers 
of children with FASD than those without [17, 58]. Smok-
ing and PAE may interact synergistically to increase the risk 
of FASD-related outcomes including low birth weight [66]. 
Proposed biologic mechanisms for the interaction between 
tobacco and alcohol include common effects on nutrient 
availability, oxidative stress and vasoconstriction of the 
placenta and umbilical cord, which can lead to hypoxia and 
prolonged uterine exposure to ethanol [5, 66, 67]. In addition 
to its interactive effect with PAE, prenatal smoking is inde-
pendently associated with reduced foetal growth, low birth-
weight and cognitive and behavioural impairment [68–75]. 
Evidence suggests that the impact of smoking on decreased 
birth weight is up to three times greater than that of PAE 
[68, 76]. Therefore, prenatal tobacco exposure can lead to 
characteristics that resemble FASD, even in the absence of 
alcohol exposure. Prenatal smoking is more common among 
mothers with an unplanned pregnancy, mothers with other 
forms of substance use, mothers who report prenatal stress, 
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younger mothers, and mothers of lower socioeconomic sta-
tus (SES) [19, 69, 73, 77].
Illicit drug use during pregnancy
Prenatal illicit drug use is more prevalent among mothers of 
children with FASD [30, 78] and it can lead to similar physi-
cal, cognitive and behavioural impairments that are relevant 
to FASD diagnosis [79, 80]. Cocaine, opiates and ampheta-
mines have been found to increase the risk of intrauterine 
growth restriction, low birth weight, small head circumfer-
ence and congenital anomalies [72, 79–81]. However, the 
effect of illicit substance exposure on birthweight and foetal 
growth is thought to be less severe and persistent than that of 
PAE and prenatal smoking [68, 71]. Children with prenatal 
illicit substance exposure may show catch-up growth [82] 
and effects are significantly attenuated following adjustment 
for adverse social factors [83]. Evidence on the effect of 
prenatal marijuana exposure on growth outcomes has been 
inconsistent [68, 71, 84]. However, marijuana use may lead 
to subtle impairments in cognitive and motor skills in child-
hood and adolescence [85–87]. In a mouse model study, 
synthetic cannabinoids were found to interact with ethanol 
to increase the prevalence of ocular defects [88].
Prenatal cocaine exposure may impair attention, speech 
and language development [89–91]. Opiate exposure can 
lead to neonatal abstinence syndrome, which is character-
ised by abnormal arousal and irritability [80, 81]. Prenatal 
amphetamine exposure has been linked to smaller subcorti-
cal volume, externalising behaviour, and cognitive deficits 
[92–94]. It is unclear whether illicit drugs modify the effects 
of PAE [83]; however, prenatal illicit drug exposure and 
PAE share common biological mechanisms of harm includ-
ing restricted blood flow to the foetus and altered neuroen-
docrine regulation [79, 95].
Prenatal illicit drug use is associated with a range of 
social and psychological factors including low socioeco-
nomic status (SES), stress, mental health problems, abuse 
and low social support [79, 83, 96]. Although maternal drug 
use may contribute to subsequent adverse social and psy-
chological outcomes, such factors are primarily perceived 
as preceding factors that increase the likelihood of drug use 
[83]. Illicit drug use increases the risk of inadequate prena-
tal care, pregnancy complications, and poor nutrition and 
is more common among older women and those with an 
unplanned pregnancy [79, 83, 95, 97].
Prenatal nutrition
Prenatal nutrition features at several points in the causal 
context of FASD. Nutrition modifies the impact of PAE 
on FASD, influences maternal BMI, and is influenced by 
maternal substance use, maternal mental health, stress, 
antenatal care, whether pregnancy was planned or not, and 
SES [5, 98–101]. Greater consumption of processed foods 
has been found to be associated with heavier alcohol intake 
and healthier diets with low-to-moderate alcohol intake dur-
ing pregnancy [102]. These associations may be due to latent 
factors such as tendencies towards healthy or unhealthy life-
style behaviours (depicted as the ‘risky behaviour’ node in 
the DAG). Among children with PAE, lower calorific intake 
has been found to increase the risk of FASD, while evidence 
from animal studies suggests that specific nutrients (includ-
ing vitamin A, docosahexaenoic acid, folate, zinc, choline, 
vitamin E, selenium, riboflavin, calcium, docosapentaenoic 
acid, zinc, B-vitamins, iron and protein) may reduce the risk 
of FASD-relevant outcomes including physical malforma-
tions, growth deficiency, behavioural regulation and memory 
[98, 99, 103–106]. During pregnancy, mothers of children 
with FASD report a lower intake of key nutrients and report 
being hungry more often than controls [59, 107]. Deficient 
nutrient intake does not, however, fully explain increased 
risk for FASD. Even with equivalent dietary intake, alcohol-
exposed rats weigh less and produce offspring with poorer 
outcomes than unexposed rats [104, 108]. Alcohol competes 
with nutrients that are essential for foetal development due 
to shared metabolic pathways [109, 110] and can lead to 
impaired placental blood flow and nutrient transportation 
[49, 98, 111, 112]. Nutritional supplementation has been 
found to attenuate FASD symptomology in some animal 
models [98]. Results in human studies are limited and incon-
sistent [113–115].
Socioeconomic status (SES)
Indicators of SES including low maternal education and 
income have been identified as risk factors for FASD [17, 
58]. Perhaps counterintuitively in light of these results, 
the UK Infant Feeding Survey has consistently found that 
women within higher social classes are more likely to drink 
during pregnancy than those from lower social classes [18, 
19, 116, 117]. UK-based cohort studies have echoed these 
results, showing that women who drink in pregnancy are 
more highly educated, less likely to live in deprived areas, 
and more likely to be employed than abstainers [37, 118, 
119]. Although high SES is associated with an increased 
risk of prenatal alcohol use, mothers of low SES who do 
drink during pregnancy are more likely to do so in a binge 
pattern [37]. As well as differences in the social patterning 
of alcohol use, children born to high SES mothers may be 
relatively protected against the harms of PAE due to fac-
tors associated with social advantage [39]. These factors are 
included in the DAG as consequences of SES and, among 
others, include differences in social support, stress, prenatal 
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nutrition and prenatal smoking, which could offer potential 
targets for intervention.
Based on the available evidence, it is hypothesised that 
SES is associated with FASD via the causal pathways pro-
posed by Abel et al. [5], in which low SES contributes to 
FASD through its influence on drinking patterns, stress, 
mental health, illicit substance use, smoking and nutrition.
Maternal age
Several studies have found that older maternal age is associ-
ated with an increased risk of FASD [17, 58]. Older moth-
ers are more likely to drink during pregnancy than younger 
mothers, although binge drinking is more common among 
younger mothers [18, 19, 116–118]. Blood alcohol concen-
tration (BAC) per unit dose increases with age, leading to 
higher levels of exposure per unit consumed among the off-
spring of older mothers [120–123]. Higher BACs may be 
partly explained by age-related changes in body composi-
tion including an increased body-fat-to-water ratio among 
older individuals [120, 122–124]. Some studies have also 
found differences in rates of ethanol metabolism among 
older participants, although results are mixed [121–123, 
125–130]. Chronic alcohol exposure, which is associated 
with maternal age, can impair nutrient transportation [112, 
131]. Thus, maternal age is proposed to influence the risk of 
FASD through differential patterns of PAE, BAC and effects 
on nutrient availability.
Marital status
Mothers of children with FASD are less likely to be mar-
ried and more likely to be cohabiting with a partner than 
controls [17]. Existing studies do not offer an explanation 
as to the causal basis of this relationship; however, it is pos-
sible that marriage may protect against FASD by offering a 
form of social support. It may also indicate fewer relation-
ship problems, which have been cited as a source of prena-
tal stress and predictor of PAE among mothers of children 
with FASD. In addition, marriage is associated with higher 
SES and lower risk of unplanned pregnancy, which predict 
a lower risk of FASD.
Religion
Esper et al. concluded that ‘less religious’ women had an 
increased risk of having a child with FASD [17]. However, 
evidence is mixed. Three South African studies found that 
mothers of children with FASD reported a lower frequency 
of church attendance and prayer than controls [33, 59, 62]. 
Conversely, studies in Italy found that women categorised 
as more religious were more likely have a child with FASD 
than those classed as less religious [64, 65]. Other studies 
have found no significant differences in the religious prac-
tices of mothers of children with FASD and those without 
[132]. These studies do not provide any insight into possible 
causal relationships between religion and FASD. However, 
the extent to which religion may protect against, or be a 
risk factor for, FASD is likely to depend on its association 
with more proximal risk factors for FASD, such as alcohol 
use, unplanned pregnancy and social support. For example, 
religions differ in their stance towards alcohol consumption. 
The Islamic faith promotes abstinence from alcohol and 
abstinence is high among Muslims [133]. The prevalence 
of FASD is 50 times lower than the global average in the 
World Health Organisation (WHO) Eastern Mediterranean 
Region, where the population is predominantly Muslim [6]. 
In contrast, wine is part of Communion in the Catholic faith 
and abstinence is much less common among Catholics [133]. 
Astley et al. found that mothers of children with FAS were 
more likely to become abstinent in the future if they reported 
a religious affiliation and more satisfactory support networks 
[134]. Finer et al. found that religion was associated with a 
reduced risk of unplanned pregnancy [135]. Therefore, reli-
gion may protect against FASD if the faith promotes absti-
nence from alcohol, or drinking in moderation, reduces the 
risk of unplanned pregnancy, and offers social support.
Parity
Parity is higher among mothers of children with FASD, 
relative to controls [17, 58]. Some authors have suggested 
that higher parity could increase susceptibility to alcohol 
teratogenicity due to greater levels of uterine collagen and 
elastin, which reduce blood flow and contribute to foetal 
hypoxia [5]. However, experimental studies suggest that it 
is maternal age, rather than parity that modifies the effect of 
PAE on offspring outcomes. When rats of the same age, but 
different parity, are exposed to equivalent levels of alcohol, 
the number of birth defects is comparable across groups. In 
contrast, older rats are more likely to produce offspring with 
birth defects following PAE than younger rats, when parity 
is equivalent [136, 137].
Pregnancy complications
Mothers of children with FASD report more complications 
including preterm delivery, foetal distress, miscarriage, 
stillbirth and admission to special care baby units [31, 33, 
138, 139]. Pre- and perinatal complications are an effect 
of PAE and may serve as a marker of exposure to factors 
associated with increased risk of FASD. Complications dur-
ing pregnancy and delivery have also been linked to other 
exposures including prenatal smoking, prenatal illicit drug 
use, poor nutrition and prenatal stress [31, 33, 95, 138–143]. 
The risk of pregnancy complications may be mitigated by 
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adherence to antenatal care recommendations and monitor-
ing [97, 144].
Antenatal care
Compared to controls, mothers of children with FASD are 
less likely to have received antenatal care, more likely to 
have accessed care late in pregnancy and more likely to 
have attended fewer antenatal appointments [30, 31, 78, 
138, 139]. Women who misuse substances may be likely 
to access prenatal care due to fear about negative staff atti-
tudes, the involvement of children’s services, and feelings 
of guilt [97]. As well as influencing uptake of antenatal 
care, prenatal substance use may be influenced by antenatal 
care. For example, mothers accessing antenatal care via the 
National Health Service (NHS) are provided with informa-
tion about the risks of prenatal substance use and support 
organisations [145]. In the USA, pregnant women who have 
health insurance are approximately 50% less likely to have 
consumed alcohol in the last month, further suggesting that 
antenatal care can influence PAE (although this relationship 
may also be due to the association between PAE and SES) 
[146]. Therefore, there is a time-dependent causal relation-
ship between PAE [and similarly other types of prenatal 
substance use (e.g. smoking, illicit drug use)] and antenatal 
care. For example, alcohol use during very early pregnancy 
(time 1) may affect attendance at the first antenatal book-
ing appointment (at 8–12 weeks in the NHS), which may 
then affect alcohol use in the second trimester (time 2) and 
so on. As it is not possible to have feedback loops within 
DAGs, the full sequence can be conceptualised as a series 
of time-dependent factors, for example: substance use before 
pregnancy → prenatal alcohol use at time 1 → attendance at 
antenatal care → prenatal alcohol use at time 2. To avoid 
over-cluttering the DAG, we depicted antenatal care as a 
consequence of prenatal substance use (time 1 relationship 
only).
Unplanned pregnancy
Worldwide, 40% of pregnancies are unplanned [147], rang-
ing from 16% in the UK [56], 35% in Africa, and 51% in 
North America [147]. Unplanned pregnancy is a risk factor 
for FASD. Among a sample of mothers of children with 
foetal alcohol syndrome (FAS) in the USA, 73% of live 
births were unplanned [134]. Unplanned pregnancy is more 
common among women who drink regularly and/or binge 
drink [53–56] and binge drinking is associated with inad-
equate methods of contraception [148]. Therefore, the risk 
of unintended PAE during the periconceptual period is high. 
Women who have an unplanned pregnancy are less likely 
than those with a planned pregnancy to follow advice for 
prenatal lifestyle behaviours including alcohol use, smoking 
and diet [52, 149, 150]. A qualitative study of pregnant 
women who attended alcohol establishments in South Africa 
suggested that some women with unplanned pregnancies 
continued to drink because they did not feel a connection 
with their unborn baby, and some women reported drinking 
in an attempt to abort the foetus [151].
Other factors associated with an increased risk of 
unplanned pregnancy include low SES, single marital status, 
exposure to intimate partner violence, smoking, illicit drug 
use and younger maternal age, while religion is associated 
with a decreased risk [53, 54, 56, 134, 135, 152]. Some of 
these factors may be causal and others may be risk markers 
for unplanned pregnancy due to their association with other 
causal factors. For example, low SES may have a causal 
relationship with unplanned pregnancy, as women may be 
less likely to commit limited financial resources to contra-
ceptives. Studies conducted in the USA show that unplanned 
pregnancy is more common among poorer women [135] 
and in one study 43% of women who gave birth to a child 
with FAS reported that they could not afford contraception 
[134]. Conversely, socioeconomic status was not found to be 
associated with unplanned pregnancy in a UK study, where 
contraception is available for free [56]. Intimate partner vio-
lence may be causally associated with unplanned pregnancy 
due to an increased risk of sexual coercion, and sabotage of 
contraception [152, 153]. Substance use before pregnancy 
may be causally associated with unplanned pregnancy, as 
it increases the likelihood of not using contraception [148, 
154]. Further consequences of unplanned pregnancy include 
late prenatal care and complications during pregnancy 
[53–55, 135, 155].
Prenatal stress
Mothers of children with FASD are more likely to report 
that pregnancy was a particularly stressful time and to 
have experienced stressful life events, including abuse and 
interpersonal violence [8, 17]. Qualitative evidence sug-
gests that some mothers may use alcohol to alleviate stress 
during pregnancy [62, 134, 151]. Prenatal stress has been 
found to predict co-occurrence of PAE, prenatal smoking, 
illicit drug use, and poor nutrition [77, 83]. It is important 
to acknowledge that substance use may also cause prenatal 
stress; however, in the literature, stress is typically thought to 
precede substance use [33]. As well as influencing drinking 
behaviour, prenatal stress may exacerbate the teratogenic 
effects of alcohol [156]. In a Ukrainian study, prenatal 
depression and PAE jointly influenced neurodevelopmen-
tal outcomes in infants. This effect may have been partially 
mediated through prenatal stress [16]. Reviews of animal 
studies have concluded that PAE and stress operate synergis-
tically to impair developmental outcomes [7]. Primate stud-
ies have found that concurrent exposure to prenatal stressors 
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exacerbate alcohol-induced behavioural and neurodevel-
opmental impairments [157, 158]. However, evidence is 
inconsistent and not all studies have found an interaction 
between PAE and stress in producing outcomes relevant to 
FASD symptomology, possibly as a result of small sample 
size [159–161].
Several biological mechanisms have been proposed to 
account for observed interactions between PAE and stress in 
FASD. One hypothesis is that PAE and prenatal stress pro-
duce lasting changes in the functioning of the foetal hypo-
thalamic–pituitary–adrenal (HPA) axis, which is involved in 
the stress response. This effect is heightened in the presence 
of both PAE and stress, relative to their individual contribu-
tion [162–164]. Endocrine dysregulation may contribute to 
the risk of FASD by influencing behavioural, cognitive and 
emotional functioning [157, 163]. Dual exposure may also 
contribute to foetal hypoxia by restricting uterine blood flow 
and suppressing foetal breathing. Hypoxia promotes cell 
damage, which may lead to midfacial abnormalities [156] 
and can be particularly damaging in areas such as the hip-
pocampus and cerebellum which are involved in attention, 
motor function and learning [5, 157]. Prenatal stress has 
been independently linked to adverse child outcomes and 
congenital anomalies and, therefore, may produce symptoms 
that resemble FASD [156, 165–168].
Maternal mental health
Mental health disorders are common among mothers of 
children with FASD [17, 32, 134]. Among a clinic-based 
sample of 80 mothers of children with FAS in the USA, 96% 
had one or more mental health disorders [134]. The mecha-
nisms that link prenatal mental health to child outcomes 
are poorly understood; however, effects are thought to be 
facilitated primarily via increased stress hormone circulation 
and altered HPA functioning, as described in the previous 
section [169–171]. Bandoli et al. found that unmedicated 
maternal depression and PAE interacted to predict poorer 
outcomes on the Bayley Scales of Infant Development 
(BSID) at ages 6 and 12 months, while maternal depres-
sion, alone, was not independently associated with neurode-
velopmental outcomes [16]. Santucci et al. also failed to 
find an association between prenatal depression and BSID 
scores [172]. Other studies have found an independent asso-
ciation between prenatal depression symptoms and poorer 
emotional–behavioural and cognitive outcomes in children 
up to age eight [100, 101]. These effects were thought to 
be partially mediated through an unhealthy prenatal diet. 
Overall, results are inconsistent with regard to the independ-
ent influence of prenatal mental health on FASD-related 
symptomology. Following a review of the evidence, Waters 
et al. concluded that, with the exception of conduct prob-
lems, prenatal depression does not appear to independently 
influence child neurodevelopmental outcomes [170]. There-
fore, associations between prenatal mental health and FASD 
are thought to be largely mediated by the prenatal stress 
response rather than mental health itself.
In addition to its interaction with PAE, maternal mental 
health may influence drinking behaviour due to the use of 
alcohol for self-medication [151, 173], as depression often 
precedes alcohol use disorder [174]. Mothers who have 
a child with FAS and subsequently receive mental health 
treatment are more likely to report abstinence, suggesting 
a promising target for FASD prevention [134]. Maternal 
mental health issues may also affect foetal development 
by increasing the risk of other adverse exposures including 
illicit substance use, smoking and poor prenatal nutrition 
[83, 100, 101, 175].
Social support in pregnancy
Social support during pregnancy is associated with reduced 
alcohol intake in European and American samples [176, 
177]. Social support may protect against PAE by attenu-
ating the impact of stressors and reducing the likelihood 
that alcohol will be used as a coping strategy. Mothers of 
children with FASD are more likely to achieve abstinence 
in the future if they report having a large, satisfactory sup-
port network [134]. However, the beneficial effects of social 
support on alcohol use may be less apparent among women 
in poverty and within subcultures that normalise drinking in 
pregnancy [151, 178].
Abuse
FASD is more common among children born to women who 
have experienced childhood physical or sexual abuse and/
or intimate partner violence [17, 32, 33, 134]. Substances 
including alcohol may be used as a self-medication strat-
egy to alleviate stress and mental health symptoms among 
those who have experienced abuse [179]. Abuse influences 
whether mothers reduce their alcohol intake following preg-
nancy recognition. 72% of mothers of children with FAS 
reported that they did not want to reduce their alcohol use 
because they were in an abusive relationship [134]. Abuse 
may also influence risk of FASD by acting as a barrier to 
adequate antenatal care. Women experiencing domestic 
abuse may be prevented from accessing antenatal care or 
may be reluctant to access care due to concerns that dis-
closure of abuse would make the situation worse, or lead to 
involvement of child protection services [97].
Maternal physical characteristics
Lower maternal height, weight and BMI have been found 
to consistently predict FASD in studies in South Africa [33, 
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58–61, 132]. Studies conducted in Italy and the USA have 
been less consistent with regard to BMI, but have found that 
mothers of children with FASD tend to be shorter or weigh 
less than those without FASD [34, 63, 78, 99]. Maternal 
physical characteristics influence the distribution of alcohol 
after it is consumed. As alcohol is distributed in body water, 
blood alcohol concentrations (BACs) tend to be higher in 
smaller women [180, 181]. As well as influencing BACs, 
higher maternal weight and BMI may indicate adequate 
nutrition. Although higher BMI may protect against FASD, 
it is important to note that maternal obesity is associated 
with a range of adverse outcomes including gestational 
diabetes mellitus, induction of labour and preterm delivery 
[182].
Maternal FASD symptomology
Mothers of children with FASD are more likely to have 
symptoms of FASD themselves, including cognitive impair-
ment and small head circumference [32, 58, 59]. Up to 94% 
of individuals with FASD have comorbid mental health 
disorders [183], including conduct disorder (91%), ADHD 
(51%), and depression (35%) [184]. In turn, impaired men-
tal health increases the risk of PAE. 55% of individuals 
with FASD experience drug or alcohol dependence later in 
life [184], thus increasing the risk of FASD in subsequent 
generations.
Knowledge and attitudes towards PAE and FASD
Public awareness of the risks of PAE is low. Inconsisten-
cies in guidance and mixed advice from health professionals 
are likely to contribute this lack of awareness [185]. A UK 
study, published in 2015, found that 40% of participants did 
not know the government guidance on PAE. Most partici-
pants (71%) also said that government guidance on PAE was 
unclear and some said that this lack of clarity was likely to 
lead to messages being disregarded [186]. Health profes-
sionals have been found to give mixed advice to women 
about PAE. The UK Infant Feeding Survey 2010 reported 
that 30% of expectant mothers were not given any informa-
tion about PAE. Among women who received advice, 36% 
were given information on reducing their intake and 29% 
on stopping drinking [19]. In the absence of clear evidence 
about a ‘safe’ threshold for PAE, opinions can be polarised. 
Some groups endorse a ‘no alcohol no risk’ message, while 
others warn against the ‘policing of pregnancy’ and sug-
gest that women should be free to make an educated choice 
about whether they drink when trying to conceive and dur-
ing pregnancy [187, 188]. Behaviour and attitudes towards 
PAE differ according to social norms and may be influenced 
by national public health policy [189].
Alcohol use of friends and family
Mothers of children with FASD report higher levels of alco-
hol consumption by their partner, family and friends [17, 
34]. Ceccanti et al. found that alcohol problems in the fam-
ily increased the likelihood of having a child with FASD 
by nine times [63]. Alcohol use by friends and family may 
impact on PAE in various ways. First, the drinking behaviour 
of those in close social networks may represent the norms 
within that context. For example, a binge pattern of drinking 
may be viewed as less problematic in some communities 
in South Africa where heavy episodic alcohol use is com-
monplace [132]. Second, some women may feel coerced 
into drinking before and during pregnancy as a result of 
the behaviour of friends and family. In a study of mothers 
of children with FAS, Astley et al. reported that 36% of 
women said that they did not want to reduce their prenatal 
alcohol intake because their partner did not want them to, 
and 20% because their family and friends did not want them 
to [134]. Strong correlations between maternal substance 
use and the substance use of friends and family could also 
be due to processes of self-selection, in which individuals 
pick companions who are similar to themselves and who 
support their behaviour [190]. In the DAG, we represented 
this mechanism via the unspecified ‘risky behaviour’ node 
that influences both maternal substance use and choice of 
social network. Finally, as described above, mothers of chil-
dren with FASD are more likely to have symptoms of FASD 
themselves and to report that the maternal grandmother has a 
history of alcohol problems [32, 59]. This raises the possibil-
ity of intergenerational transmission of FASD, a phenom-
enon that has received support via controlled animal studies 
[191]. Heavy alcohol use by the maternal grandmother could 
indicate the presence of a risk genotype for heavy alcohol 
use [192], could result in epigenetic changes that increase 
the risk of heavy alcohol use in later generations [191] and 
could provide a model of problematic alcohol use that is 
adopted by offspring via social learning [193]. Recent evi-
dence from animal studies suggests that paternal alcohol 
consumption could influence the epigenetics of sperm DNA 
by influencing methylation patterns in sites that are impor-
tant to developmental outcomes [194]. Paternal alcohol use 
has been associated with FASD symptomology including 
low birth weight, reduced brain size, microcephaly, impaired 
learning and hyperresponsiveness [42, 195], although results 
have been inconsistent [196].
Having another child with FASD
An early study, published in 1979, found that 70% of chil-
dren with FAS had a sibling with confirmed or suspected 
FAS [197]. In the FAS Surveillance Network, between 9 and 
29% of mothers have another child with FASD [30]. Having 
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another child with FASD is also a strong predictor of subse-
quent alcohol-exposed pregnancies [30, 31, 197, 198]. In a 
cross-sectional study of mothers of children with FAS, 80% 
subsequently had an unplanned pregnancy, of which 75% 
were alcohol exposed [134]. In the absence of intervention, 
women who are at risk of having another child with FASD 
may exist within the same causal context as that which sur-
rounded their first affected pregnancy. Thus, identifying 
mothers who have had a child with FASD is an important 
focus for targeted prevention [198].
Genetics
Genetic factors modify susceptibility to alcohol-related harm 
[192, 199–201]. Dizygotic twins have differential suscepti-
bility to FASD, while monozygotic twins have high levels 
of concordance [202–205], different strains of mice have 
diverse outcomes according to their genotype [206, 207] 
and particular genetic variants are more common among 
alcohol-exposed children who develop FASD, compared to 
those who do not [208, 209]. A range of genes have been 
investigated in animal models of FASD, including aldehyde 
dehydrogenase (ALDH), Fancd2, Cdon, Gli2, Shh, Nos1, 
PDGFRA, hinfp, foxi1, mars, plk1 and vangl2; however, 
these genes are yet to be explored in human studies [201]. 
In humans, polymorphisms of alcohol dehydrogenase 
(ADH) genes have been the primary focus of investiga-
tion [199–201]. ADH enzymes oxidise ethanol to acetal-
dehyde and account for up to 95% of alcohol metabolism. 
ALDH and CYPE2E1 also influence ethanol metabolism in 
humans; however, their role in FASD susceptibility is yet to 
be established [200, 208]. Polymorphisms at the ADH1B 
locus produce enzymes that affect the rate of ethanol clear-
ance. In populations of European ancestry, the slow-metab-
olising allele, ADH1B*1, is the typical variant and occurs 
in approximately 95% of individuals. The rare ADH1B*2 
and ADH1B*3 alleles convert ethanol to acetaldehyde 75-88 
times faster than ADH1B*1 [210]. Maternal and infant 
ADH1B genotype has been found to influence risk of FASD 
as, with the exception of one study [211], fast-metabolising 
alleles have been associated with a reduced risk of FASD 
symptomology following PAE [208, 212–215].
Lewis et al. explored the impact of ADH polymorphisms 
on children’s IQ following PAE [38]. Rare variants of four 
child single nucleotide polymorphisms (SNPs; ADH7 
rs284779, ADH1B rs4147536, ADH1A rs975833 and 
ADH1A rs2866151; herein referred to as the SNP set) were 
negatively associated with IQ at age eight for children with 
low to moderate alcohol exposure in utero (1–6 units per 
week). These rare variants were hypothesised to be associ-
ated with slower metabolism, leading to relatively increased 
alcohol exposure and teratogenicity [38, 216]. However, a 
study of in vivo alcohol metabolism failed to show that these 
SNPs influenced blood or breath alcohol concentrations 
[217]. Within this study, another SNP, ADH4 rs4148884, 
had divergent effects. The rare allele was associated with 
decreased offspring IQ when present in the maternal geno-
type, but increased IQ when present in the child’s genotype. 
These SNPs were not associated with IQ among children of 
non-drinking mothers, suggesting that genotype acted as an 
effect modifier following maternal alcohol intake.
As well as influencing alcohol metabolism, genotype may 
influence drinking behaviour and, hence, the interest in ADH 
variants as instrumental variables in Mendelian randomisa-
tion studies [12]. Patterns of alcohol consumption tend to 
run in families and several genes have been found to con-
tribute to risk of alcoholism [192, 196]. ADH1B has been 
widely studied and research shows that individuals with the 
rare allele consume less alcohol than those with the typical 
allele and have a reduced risk of alcoholism [218–221]. In 
pregnancy, mothers with the rare ADH1B allele have been 
found to consume significantly less alcohol before preg-
nancy and to be 50% less likely to binge drink during preg-
nancy [222]. Therefore, genotype may influence the risk of 
FASD through its influence on both alcohol metabolism and 
drinking behaviour [37].
Using the DAG to support causal inferences 
and statistical analyses
To demonstrate how the DAG presented in this review can 
be used to clarify the causal pathways to FASD and to sup-
port statistical modelling strategies, we present a worked 
example using prenatal smoking as the risk factor of interest. 
We replicated the causal structure depicted in Fig. 1 in the 
DAGitty platform [27]. In all circumstances, there must have 
been prenatal alcohol exposure for there to be true FASD. 
The representation of the DAG that includes smoking as the 
key co-exposure in DAGitty is shown in Fig. 2.
There were six hypothesised causal pathways that 
accounted for the total causal effect of prenatal smoking on 
FASD classification among children with PAE.
These were
1. Prenatal smoking → ‘true’ FASD (unobserved) → FASD 
classification
2. Prenatal smoking → prenatal nutrition → ‘true’ FASD 
(unobserved) - > FASD classification
3. Prenatal smoking → prenatal nutrition → BMI → ‘true’ 
FASD (unobserved) → FASD classification
4. Prenatal smoking → characteristics that resemble 
FASD → FASD classification
5. Prenatal smoking → prenatal nutrition → characteristics 
that resemble FASD → FASD classification
6. Prenatal smoking → prenatal nutrition → BMI → char-
acteristics that resemble FASD → FASD classification
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Pathways 1–3 describe participants who have a pattern 
of symptoms that met the criteria for FASD and whose 
symptoms were caused by PAE. These are the participants 
with ‘true FASD.’ In contrast, pathways 4–6 describe par-
ticipants who have characteristics that resemble FASD, 
but whose presentation has been caused by factors other 
than alcohol exposure. In practice, and in the absence of 
the full facial phenotype for FASD, it is often difficult to 
determine whether the characteristics that contribute to a 
diagnosis were caused by prenatal alcohol exposure or other 
factors and this requires expert clinical judgement. All these 
pathways contribute to the total prevalence of FASD that is 
observed. Based on the graphical rules described in Online 
Resource 1 and operationalised by DAGitty, if the postulated 
DAG is correct, with no omitted common causes of any two 
nodes and no measurement error (these are strong assump-
tions), then an unbiased estimate of the total causal effect of 
prenatal smoking on FASD could be obtained by adjusting 
for the following variables in the analysis: maternal age at 
pregnancy, prenatal mental health, maternal ‘risky behav-
iour’ (e.g. personality trait variable), SES, prenatal stress 
and unplanned pregnancy. It is important to bear in mind that 
DAGitty provides, if one exists, a minimally sufficient adjust-
ment set (i.e. the minimum set of variables that is required 
to eliminate bias). In this smoking example, the minimally 
sufficient adjustment set suggested by the DAG was mater-
nal age, mental health, risky behaviour, SES, stress and 
unplanned pregnancy. The researcher interested in pursuing 
this could enter these variables into a multivariable statisti-
cal model to minimise bias in the estimate of the total casual 
effect of prenatal smoking on FASD classification. If the 
number of events is low, then limiting to the minimal adjust-
ment set may be a good idea. In practice, if the data allow 
further adjustment without running into numerical problems 
or issues of finite sample bias, then adjusting for additional 
predictors of the outcome is advisable, as this will lead to a 
more precise estimate which is still unbiased. It is important 
to check, however, that the inclusion of these additional vari-
ables does not induce bias. To check that adjustment for an 
additional variable is not going to induce bias, one can add 
candidate variables to the adjustment set in DAGitty to see if 
this creates biasing pathways between the exposure and the 
outcome. Online Resource 1 provides further explanation of 
when adjustment can lead to bias.
Discussion
The aetiology of FASD is multifaceted and complex. The 
DAG that we have presented provides a summary of the dis-
tal and proximal factors that are proposed to causally influ-
ence FASD risk, as well as the factors that are proxies for 
causal factors or (non-causal) risk markers for FASD. Prior 
to pregnancy, multiple distal factors influence pregnancy 
planning and lifestyle choices including pre-pregnancy alco-
hol use. These factors are proposed to influence subsequent 
prenatal alcohol exposure. Following prenatal exposure to 
alcohol, FASD risk is determined by a range of lifestyle, 
sociodemographic, maternal, social, gestational and genetic 
factors that mutually influence children’s outcomes. The use 
of causal diagram theory as the underpinning framework 
for this evidence synthesis allows us to move beyond dis-
cussion of association to make inferences about potential 
causal relationships between factors relevant to FASD. The 
principles of causal diagram theory can be applied to this 
DAG to inform study design and statistical modelling strate-
gies for FASD research.
Strengths and limitations
Literature review and DAG methodology
The literature review and DAG that we have presented build 
upon existing reviews of risk factors for FASD [17, 99, 223] 
and provide an updated synthesis using the latest evidence. 
The use of DAG methodology represents a novel approach to 
the study of FASD and adds clarity to causal inferences in an 
area that has mostly been confined to discussions of associa-
tion. As a visual representation, the DAG presents a unified 
summary of the current evidence on the aetiology of FASD.
Since the DAG has been constructed based on current 
subject-matter knowledge and our interpretation of plausi-
ble causal structures, it may be subject to change as new 
evidence emerges. This is not a limitation of the DAG 
approach, but rather reflects the realities of making causal 
inferences within a developing evidence base. In its current 
form, the DAG that we have presented may be a useful work-
ing template for researchers of FASD, who can use this tool 
to guide their analyses and update the causal structure of 
the DAG, as necessary. DAGitty code is provided in Online 
Resource 3 and can be copied and pasted into the DAGitty 
platform to replicate the DAG that we present in this review. 
Users can then use DAGitty to inform their own modelling 
strategy, based on this DAG and/or update the DAG based 
on their own hypotheses and emerging evidence.
The DAG may also help researchers at the design stage, 
by indicating which variables are important to measure. It 
is important to note that the causal inferences derived from 
the DAG rest on the assumption that the diagram is valid. 
The DAG is based on our interpretation of the evidence and, 
therefore, it is possible that given the same evidence other 
researchers may depict the relationships differently. Further-
more, the limitations inherent in the evidence base will nec-
essarily apply to the results from this review and the DAG. 
Many proposed risk factors for FASD, such as prenatal 
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substance exposure and maternal stress, cannot be manipu-
lated for ethical and practical reasons [224]. The evidence 
that we have used to construct the DAG was, therefore, 
based on experimental studies with animals and observa-
tional studies with humans. Animal studies have allowed the 
causal status of ethanol as a teratogen to be established [225] 
and have enabled causal conclusions about the influence of 
covariates such as stress and genetics on outcomes relevant 
to FASD [159, 207, 226]. Furthermore, in contrast to human 
studies, in which adverse exposures and health behaviours 
tend to co-occur, animal studies can isolate and evaluate the 
effects of specific exposures. However, animal models are 
imperfect substitutes for human studies for reasons including 
differences in alcohol metabolism, gestational processes, and 
their inability to replicate higher-level behavioural outcomes 
[7]. No single animal model has replicated all the attributes 
of FASD [225]. Observational studies of humans pose fewer 
concerns than animal studies in terms of exploring associa-
tions between a variety of co-occurring social and lifestyle 
factors and the full spectrum of FASD. However, this advan-
tage is countered by the potential for bias due to the lack of 
experimental control. In general, observational studies are at 
risk of bias due to residual confounding, misclassification of 
the exposure and/or outcome, and differential loss to follow-
up. In the evidence synthesis for the DAG, as well as studies 
with traditional observational designs, we included negative 
control and Mendelian randomisation studies. These stud-
ies are also subject to potential limitations. The contribu-
tion of paternal epigenetic factors to prenatal development 
in negative control studies remains to be established and 
effect estimates may be biased and imprecise in Mendelian 
randomisation studies if genetic instruments are weakly cor-
related with the exposure of interest and/or the instruments 
are invalid due to pleiotropy) [42, 221, 222, 227]. Neverthe-
less, the sources of bias differ for each approach and, under 
a triangulation method, the fact that the evidence from these 
different study designs points to a similar causal conclu-
sion for many of the nodes of interest increases confidence 
in the causal hypotheses presented in the DAG [227, 228]. 
However, it may never be possible to determine whether the 
pathways suggested by the observational and animal stud-
ies represent the true causal pathways to FASD. Although 
this is a limitation of causal inference in general, compared 
to conventional statistical modelling strategies, approaches 
that make use of DAGs, when used sensibly, benefit from 
the increased transparency about causal assumptions and 
highlight likely remaining sources of bias.
The utility of DAGs in casual inference
Recently, there have been some criticisms about the gain 
in popularity of DAGs as tools to support causal inference. 
Kreiger and Davey Smith argue that DAGs have become 
synonymous with ‘casual inference’ and that this unneces-
sarily narrows the scope of causal inquiry in epidemiology 
[228]. They assert that “robust causal inference…com-
prises a complex narrative, created by scientists apprais-
ing, from diverse perspectives, different strands of evi-
dence produced by myriad methods. DAGs can of course 
be useful, but should not alone wag the causal tale” [228] 
(p. 1789). We agree, and this is why we have drawn upon 
a broad body of evidence to support the causal pathways 
depicted in the DAG. Daniel et al. have countered that 
DAGs do not purport to provide a substitute for careful 
consideration of the evidence base. Instead they should be 
a result of this [229]. Under this view, we would contend 
that the narrative synthesis that we have conducted is an 
example of the approach encouraged by the causal infer-
ence ‘school’ of Pearl et al. [14, 230, 231], while the DAG 
is the tool that summarises key causal assumptions and 
enables application of graphical rules to guide appropriate 
analyses and interpretation.
Finally, DAGs are nonparametric and thus often attract 
criticism for not formally allowing the concept of effect 
modification to be visualised. This is particularly relevant 
when trying to describe the aetiological context of FASD. 
In this context, while there is a sole necessary cause (alco-
hol), several effect modifiers may be present that influence 
whether PAE results in FASD. If one views the DAG solely 
as a means of deciding on an adjustment set, then there is 
no need to depict effect modification. However, if (as we 
have done here), the DAG is also used as a visual summary 
of existing evidence in this area, then it is useful to enhance 
the DAG with a depiction of effect modification. In the DAG 
(Fig. 1), we have followed Weinberg [232] and Thompson’s 
[233] suggestion by representing effect modification with an 
arrow that intersects the intermediate causal pathway from 
PAE to FASD, although other representations have been sug-
gested [234, 235]. The representation of effect modification 
as an intersecting arrow in the direct pathway between PAE 
and FASD is purely for visual illustration. To enable analysis 
in the DAGitty platform, we directly connected the arrows 
from the proposed effect modifiers to the FASD outcome 
to allow application of the graphical rule algorithms [236].
Conclusions
The DAG presented in this review formalises and unifies 
current knowledge about the causal context of FASD. We 
believe that this DAG provides a useful synthesis of evi-
dence for those interested in the aetiology of FASD and 
can be used as a tool to strengthen data collection and 
analysis strategies in studies of FASD risk factors.
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